Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
Public ClinicalTrials.gov record NCT01373151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIB , Randomized, Multi-Center, Double-Blind, Dose-Ranging, Placebo/Active Controlled Study to Evaluate the Efficacy and Safety of BMS-945429 Subcutaneous Injection With or Without Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Methotrexate.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effective dose of BMS-945429 in subjects with inadequate response to Methotrexate in the treatment of moderate to severe Rheumatoid Arthritis.
Study identification
- NCT ID
- NCT01373151
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 418 participants
Conditions and interventions
Conditions
Interventions
- BMS-945429 Placebo Drug
- BMS-945429 Biological
- Methotrexate Drug
- Methotrexate Placebo Drug
- Adalimumab Placebo Drug
- Adalimumab Drug
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2011 (Type not available)
- Primary completion
- Sep 2012 (Actual)
- Completion
- Jun 2015 (Actual)
- Last update posted
- Dec 6, 2021
2011 – 2015
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sun Valley Arthritis Center, Ltd. | Peoria | Arizona | 85381 | — |
| San Diego Arthritis Medical Clinic | San Diego | California | 92108 | — |
| New England Research Associates, Llc | Trumbull | Connecticut | 06611 | — |
| Quincy Medical Group | Quincy | Illinois | 62301 | — |
| Rockford Orthopedic Associates, Llc. | Rockford | Illinois | 61107 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| Arthritis Associates Of Mississippi | Jackson | Mississippi | 39202 | — |
| Physician Research Collaboration, Llc | Lincoln | Nebraska | 68516 | — |
| Box Arthritis And Rheumatology Of The Carolinas, Pllc | Charlotte | North Carolina | 28210 | — |
| Health Research Of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| East Penn Rheumatology Associates, P.C. | Bethlehem | Pennsylvania | 18015 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Seattle Rheumatology Associates | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01373151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01373151 live on ClinicalTrials.gov.